Cargando…

Immunohistochemical Analysis of CXCR4 Expression in Fibrohistiocytic Tumors

Functional chemokine receptors are expressed in many malignant tumors. These receptors promote tumor growth and metastasis in response to endogenous chemokines. We analyzed the expression of CXCR4, CCR6 and CCR7 in fibrohistiocytic tumors, including dermatofibrosarcoma protuberance (DFSP), malignant...

Descripción completa

Detalles Bibliográficos
Autores principales: Toyozawa, Seiko, Yamamoto, Yuki, Ishida, Yuko, Kondo, Toshikazu, Nakamura, Yasushi, Furukawa, Fukumi
Formato: Texto
Lenguaje:English
Publicado: Japan Society of Histochemistry and Cytochemistry 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875858/
https://www.ncbi.nlm.nih.gov/pubmed/20514291
http://dx.doi.org/10.1267/ahc.10003
_version_ 1782181639371096064
author Toyozawa, Seiko
Yamamoto, Yuki
Ishida, Yuko
Kondo, Toshikazu
Nakamura, Yasushi
Furukawa, Fukumi
author_facet Toyozawa, Seiko
Yamamoto, Yuki
Ishida, Yuko
Kondo, Toshikazu
Nakamura, Yasushi
Furukawa, Fukumi
author_sort Toyozawa, Seiko
collection PubMed
description Functional chemokine receptors are expressed in many malignant tumors. These receptors promote tumor growth and metastasis in response to endogenous chemokines. We analyzed the expression of CXCR4, CCR6 and CCR7 in fibrohistiocytic tumors, including dermatofibrosarcoma protuberance (DFSP), malignant fibrous histiocytoma (MFH), dermatofibroma (DF) using immunohistochemistry. We also investigated the relationship between CXCR4 and CD34, the latter of which is an immunohistochemical marker for DFSP. We observed a higher expression of CXCR4 in DFSP and MFH as compared with DF. Interestingly, a significantly higher expression of CXCR4 was detected in relapsed DFSP than in non-relapsed DFSP, but no significant differences were detected between non-relapsed DFSP and DFSP with CD34 immunostaining. Moreover, MFH had strong immunoreactivity for CXCR4, CCR6 and CCR7. These findings suggest that the assessment of CXCR4 immunoreactivity in fibrohistiocytic tumors is a useful tool for predicting tumor aggressiveness.
format Text
id pubmed-2875858
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Japan Society of Histochemistry and Cytochemistry
record_format MEDLINE/PubMed
spelling pubmed-28758582010-05-28 Immunohistochemical Analysis of CXCR4 Expression in Fibrohistiocytic Tumors Toyozawa, Seiko Yamamoto, Yuki Ishida, Yuko Kondo, Toshikazu Nakamura, Yasushi Furukawa, Fukumi Acta Histochem Cytochem Regular Article Functional chemokine receptors are expressed in many malignant tumors. These receptors promote tumor growth and metastasis in response to endogenous chemokines. We analyzed the expression of CXCR4, CCR6 and CCR7 in fibrohistiocytic tumors, including dermatofibrosarcoma protuberance (DFSP), malignant fibrous histiocytoma (MFH), dermatofibroma (DF) using immunohistochemistry. We also investigated the relationship between CXCR4 and CD34, the latter of which is an immunohistochemical marker for DFSP. We observed a higher expression of CXCR4 in DFSP and MFH as compared with DF. Interestingly, a significantly higher expression of CXCR4 was detected in relapsed DFSP than in non-relapsed DFSP, but no significant differences were detected between non-relapsed DFSP and DFSP with CD34 immunostaining. Moreover, MFH had strong immunoreactivity for CXCR4, CCR6 and CCR7. These findings suggest that the assessment of CXCR4 immunoreactivity in fibrohistiocytic tumors is a useful tool for predicting tumor aggressiveness. Japan Society of Histochemistry and Cytochemistry 2010-05-01 2010-04-07 /pmc/articles/PMC2875858/ /pubmed/20514291 http://dx.doi.org/10.1267/ahc.10003 Text en © 2010 The Japan Society of Histochemistry and Cytochemistry This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Regular Article
Toyozawa, Seiko
Yamamoto, Yuki
Ishida, Yuko
Kondo, Toshikazu
Nakamura, Yasushi
Furukawa, Fukumi
Immunohistochemical Analysis of CXCR4 Expression in Fibrohistiocytic Tumors
title Immunohistochemical Analysis of CXCR4 Expression in Fibrohistiocytic Tumors
title_full Immunohistochemical Analysis of CXCR4 Expression in Fibrohistiocytic Tumors
title_fullStr Immunohistochemical Analysis of CXCR4 Expression in Fibrohistiocytic Tumors
title_full_unstemmed Immunohistochemical Analysis of CXCR4 Expression in Fibrohistiocytic Tumors
title_short Immunohistochemical Analysis of CXCR4 Expression in Fibrohistiocytic Tumors
title_sort immunohistochemical analysis of cxcr4 expression in fibrohistiocytic tumors
topic Regular Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875858/
https://www.ncbi.nlm.nih.gov/pubmed/20514291
http://dx.doi.org/10.1267/ahc.10003
work_keys_str_mv AT toyozawaseiko immunohistochemicalanalysisofcxcr4expressioninfibrohistiocytictumors
AT yamamotoyuki immunohistochemicalanalysisofcxcr4expressioninfibrohistiocytictumors
AT ishidayuko immunohistochemicalanalysisofcxcr4expressioninfibrohistiocytictumors
AT kondotoshikazu immunohistochemicalanalysisofcxcr4expressioninfibrohistiocytictumors
AT nakamurayasushi immunohistochemicalanalysisofcxcr4expressioninfibrohistiocytictumors
AT furukawafukumi immunohistochemicalanalysisofcxcr4expressioninfibrohistiocytictumors